US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on July 13, 2026

Jul. 13, 2026

Acentra Health Appoints Michael Kingston as Chief Digital & Information Officer to Lead Technology and AI Innovation

Indeterminate GlobeNewswire

Jul. 13, 2026

Aegis Treatment Centers Opens New Medication Unit in Yreka, Opening Up Access to Opioid Treatment in Siskiyou County

Indeterminate GlobeNewswire

Jul. 13, 2026

Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

Indeterminate GlobeNewswire

Jul. 13, 2026

Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire

Jul. 13, 2026

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Indeterminate GlobeNewswire

Jul. 13, 2026

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

Indeterminate GlobeNewswire

Jul. 13, 2026

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Jul. 13, 2026

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Indeterminate GlobeNewswire

Jul. 13, 2026

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

Indeterminate GlobeNewswire

Jul. 13, 2026

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

Indeterminate GlobeNewswire

Jul. 13, 2026

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Indeterminate GlobeNewswire

Jul. 13, 2026

Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection

Indeterminate GlobeNewswire

Jul. 13, 2026

Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Indeterminate GlobeNewswire

Jul. 13, 2026

Apollomics Regains Full Compliance with Nasdaq Listing Requirements

Indeterminate GlobeNewswire

Jul. 13, 2026

FDA Grants De Novo Classification to Claria Medical for Device Designed to Improve Safety and Efficiency of Hysterectomy Procedures

Indeterminate GlobeNewswire

Jul. 13, 2026

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to…

Indeterminate GlobeNewswire

Jul. 13, 2026

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Indeterminate GlobeNewswire

Jul. 13, 2026

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Indeterminate GlobeNewswire

Jul. 13, 2026

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

Indeterminate GlobeNewswire

Jul. 13, 2026

Bexorg Expands Leadership Team with Appointments of Bruce Car, Ph.D., as Chief Scientific Officer and Michael Fenn, Ph.D., as Chief Business Officer

Indeterminate GlobeNewswire